For a closer look at the antioxidant side, see our cross-cluster guide to glutathione IV therapy while being clear that raising glutathione is supportive, not a stand-alone treatment for confirmed toxicity
Despite a significant improvement in the treatment of T2D and CVD over the past few decades, reducing CVD in patients with T2D solely with an optimal glycemic control has been challenging [2]
When progress is steady and treatment feels well-tolerated, theres every reason to continue
Abstract: We demonstrated for the first time that a marine-derived antimicrobial peptide (AMP), Sph_12-38, exhibit high antimicrobial activity against P
That's why the FDA approval of Lipfendra (enlicitide)-the very first once-daily pill in this class of heart medications is such a big deal
Y., Shimura, N., Konishi, T., Sauchi, Y., Wada, S., Aoi, W.,